These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 10844103)

  • 61. Idalopirdine - a small molecule antagonist of 5-HT6 with therapeutic potential against obesity.
    Dudek M; Marcinkowska M; Bucki A; Olczyk A; Kołaczkowski M
    Metab Brain Dis; 2015 Dec; 30(6):1487-94. PubMed ID: 26419385
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Sibutramine effects on the reproductive performance of pregnant overweight and non-overweight rats.
    Francia-Farje LA; Silva DS; Volpato GT; Fernandes GS; Carnietto N; Cicogna AC; Kempinas Wde G
    J Toxicol Environ Health A; 2010; 73(13-14):985-90. PubMed ID: 20563932
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Central nervous system biogenic amine targets for control of appetite and energy expenditure.
    Nelson DL; Gehlert DR
    Endocrine; 2006 Feb; 29(1):49-60. PubMed ID: 16622292
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Paradoxical effect of sibutramine on autonomic cardiovascular regulation in obese hypertensive patients--sibutramine and blood pressure.
    Birkenfeld AL; Schroeder C; Pischon T; Tank J; Luft FC; Sharma AM; Jordan J
    Clin Auton Res; 2005 Jun; 15(3):200-6. PubMed ID: 15944869
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Effect of sibutramine on macronutrient selection in male and female rats.
    LeBlanc M; Thibault L
    Physiol Behav; 2003 Nov; 80(2-3):243-52. PubMed ID: 14637222
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Modulation of sibutramine-induced increases in extracellular noradrenaline concentration in rat frontal cortex and hypothalamus by alpha2-adrenoceptors.
    Wortley KE; Heal DJ; Stanford SC
    Br J Pharmacol; 1999 Oct; 128(3):659-66. PubMed ID: 10516646
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The novel triple monoamine reuptake inhibitor tesofensine induces sustained weight loss and improves glycemic control in the diet-induced obese rat: comparison to sibutramine and rimonabant.
    Hansen HH; Hansen G; Tang-Christensen M; Larsen PJ; Axel AM; Raben A; Mikkelsen JD
    Eur J Pharmacol; 2010 Jun; 636(1-3):88-95. PubMed ID: 20385125
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Evaluation of body fat composition after linagliptin treatment in a rat model of diet-induced obesity: a magnetic resonance spectroscopy study in comparison with sibutramine.
    Klein T; Niessen HG; Ittrich C; Mayoux E; Mueller HP; Cheetham S; Stiller D; Kassubek J; Mark M
    Diabetes Obes Metab; 2012 Nov; 14(11):1050-3. PubMed ID: 22651241
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The primary amine metabolite of sibutramine stimulates lipolysis in adipocytes isolated from lean and obese mice and in isolated human adipocytes.
    Richardson DK; Jones RB; Bailey CJ
    Horm Metab Res; 2006 Nov; 38(11):727-31. PubMed ID: 17111299
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Intranigral or intrastriatal injections of GDNF: effects on monoamine levels and behavior in rats.
    Martin D; Miller G; Cullen T; Fischer N; Dix D; Russell D
    Eur J Pharmacol; 1996 Dec; 317(2-3):247-56. PubMed ID: 8997607
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Pharma-clinics. Medication of the month. Sibutramine (Reductil)].
    Scheen AJ
    Rev Med Liege; 2001 Sep; 56(9):656-9. PubMed ID: 11702509
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The development of tolerance to drugs that suppress food intake.
    Fernstrom JD; Choi S
    Pharmacol Ther; 2008 Jan; 117(1):105-22. PubMed ID: 17950459
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Can Spirulina maxima reduce the mutagenic potential of sibutramine?
    Araldi RP; Santos NP; Mendes TB; Carvalho LB; Ito ET; de-Sá-Júnior PL; Souza EB
    Genet Mol Res; 2015 Dec; 14(4):18452-64. PubMed ID: 26782493
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Sibutramine and its cardiovascular profile.
    Narkiewicz K
    Int J Obes Relat Metab Disord; 2002 Dec; 26 Suppl 4():S38-41. PubMed ID: 12457299
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Who will lose weight on sibutramine and orlistat? Psychological correlates for treatment success.
    Elfhag K; Finer N; Rössner S
    Diabetes Obes Metab; 2008 Jun; 10(6):498-505. PubMed ID: 17593239
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Comparison of changes in the extracellular concentration of noradrenaline in rat frontal cortex induced by sibutramine or d-amphetamine: modulation by alpha2-adrenoceptors.
    Wortley KE; Hughes ZA; Heal DJ; Stanford SC
    Br J Pharmacol; 1999 Aug; 127(8):1860-6. PubMed ID: 10482917
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Detection of sibutramine administration: a gas chromatography/mass spectrometry study of the main urinary metabolites.
    Strano-Rossi S; Colamonici C; Botrè F
    Rapid Commun Mass Spectrom; 2007; 21(2):79-88. PubMed ID: 17154357
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [The "problem obesity": viewpoint of the internist].
    Guagnano MT; Manigrasso MR; Capani F; Davì G
    Ann Ital Chir; 2005; 76(5):407-11. PubMed ID: 16696212
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Sibutramine and thermogenesis in humans.
    Danforth E
    Int J Obes Relat Metab Disord; 1999 Oct; 23(10):1007-8. PubMed ID: 10557019
    [No Abstract]   [Full Text] [Related]  

  • 80. Interaction between sibutramine and cyclosporine.
    Clerbaux G; Goffin E; Pirson Y
    Am J Transplant; 2003 Jul; 3(7):906. PubMed ID: 12814485
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.